The Clinical Effect of Electroconvulsive Therapy and Its Relationship with Serum Levels of MMP-9 and CXCL12 in Patients with Mania

References

• Stripp TK, Jorgensen MB, Olsen NV. Anaesthesia for electroconvulsive therapy–new tricks for old drugs: a systematic review. Acta Neuropsychiatr. 2018;30(2):61–69. doi:10.1017/neu.2017.1228462732
   PubMed Web of Science ®Google Scholar
• Rudorfer MV, Henry ME, Sackeim HA. Electroconvulsive therapy. Psychiatry. 2003;2:1865–1901.
   Google Scholar
• Coffey MJ, Cooper JJ. Therapeutic uses of seizures in neuropsychiatry. Focus (Am Psychiatr Publ). 2019;17(1):13–17. doi:10.1176/appi.focus.2018002331975954
   PubMedGoogle Scholar
• Salik I, Marwaha R. Electroconvulsive Therapy. StatPearls. Treasure Island (FL): StatPearls Publishing StatPearls Publishing LLC.; 2020.
   Google Scholar
• van Rossum D, Hanisch U-K. Microglia. Metab Brain Dis. 2004;19(3–4):393–411. doi:10.1023/B:MEBR.0000043984.73063.d815554430
   PubMed Web of Science ®Google Scholar
• Hanisch UK. Microglia as a source and target of cytokines. Glia. 2002;40(2):140–155. doi:10.1002/glia.1016112379902
   PubMed Web of Science ®Google Scholar
• Guloksuz S, Rutten BP, Arts B, van Os J, Kenis G. The immune system and electroconvulsive therapy for depression. J ECT. 2014;30(2):132–137. doi:10.1097/YCT.000000000000012724755720
   PubMed Web of Science ®Google Scholar
• Chen F, Madsen TM, Wegener G, Nyengaard JR. Repeated electroconvulsive seizures increase the total number of synapses in adult male rat hippocampus. Eur Neuropsychopharmacol. 2009;19(5):329–338. doi:10.1016/j.euroneuro.2008.12.00719176277
   PubMed Web of Science ®Google Scholar
• Wennström M, Hellsten J, Tingström A. Electroconvulsive seizures induce proliferation of NG2-expressing glial cells in adult rat amygdala. Biological psychiatry. 2004;55(5):464–471. doi:10.1016/j.biopsych.2003.11.01115023573
   PubMed Web of Science ®Google Scholar
• van Buel EM, Patas K, Peters M, Bosker FJ, Eisel UL, Klein HC. Immune and neurotrophin stimulation by electroconvulsive therapy: is some inflammation needed after all? Transl Psychiatry. 2015;5(7):e609–e. doi:10.1038/tp.2015.10026218851
   PubMed Web of Science ®Google Scholar
• Rush G, O’donovan A, Nagle L, et al. Alteration of immune markers in a group of melancholic depressed patients and their response to electroconvulsive therapy. J Affect Disord. 2016;205:60–68. doi:10.1016/j.jad.2016.06.03527414954
   PubMed Web of Science ®Google Scholar
• Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016;16(1):22. doi:10.1038/nri.2015.526711676
   PubMed Web of Science ®Google Scholar
• Hermida AP, Glass OM, Shafi H, McDonald WM. Electroconvulsive therapy in depression: current practice and future direction. Psychiatric Clin. 2018;41(3):341–353. doi:10.1016/j.psc.2018.04.001
   PubMed Web of Science ®Google Scholar
• Oltedal L, Narr KL, Abbott C, et al. Volume of the human hippocampus and clinical response following electroconvulsive therapy. Biological Psychiatry. 2018;84(8):574–581. doi:10.1016/j.biopsych.2018.05.01730006199
   PubMed Web of Science ®Google Scholar
• Akbari M, Afkhami-ardekani M, Eslami M. Effects of electroconvulsive therapy on thyroid function parameters in depressed patients. J Shahid Sadoughi Univ Med Sci. 2008;16(3):312.
   Google Scholar
• Kaminari A, Tsilibary EC, Tzinia A. A new perspective in utilizing MMP-9 as a therapeutic target for Alzheimer’s disease and type 2 diabetes mellitus. J Alzheimer’s Dis. 2018;64(1):1–16. doi:10.3233/JAD-18003529865065
   PubMed Web of Science ®Google Scholar
• Ellies LG, Hingorani DV, Lippert CN, et al. Impact of MMP-2 and MMP-9 activation on wound healing, tumor growth and RACPP cleavage. BioRxiv. 2018;327791.
   Google Scholar
• Akbarzadeh M, Movassaghpour AA, Ghanbari H, et al. The potential therapeutic effect of melatonin on human ovarian cancer by inhibition of invasion and migration of cancer stem cells. Sci Rep. 2017;7(1):17062. doi:10.1038/s41598-017-16940-y29213108
   PubMed Web of Science ®Google Scholar
• Qu J, Zhao H, Li Q, et al. MST1 suppression reduces early brain injury by inhibiting the NF-κB/MMP-9 pathway after subarachnoid hemorrhage in mice. Behav Neurol. 2018;2018. doi:10.1155/2018/6470957
   Web of Science ®Google Scholar
• Chelluboina B, Nalamolu KR, Klopfenstein JD, et al. MMP-12, a promising therapeutic target for neurological diseases. Mol Neurobiol. 2018;55(2):1405–1409. doi:10.1007/s12035-017-0418-528155200
   PubMed Web of Science ®Google Scholar
• Sweeney MD, Sagare AP, Zlokovic BV. Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol. 2018;14(3):133. doi:10.1038/nrneurol.2017.18829377008
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang H, Lin S, et al. SDF-1/CXCR7 chemokine signaling is induced in the peri-infarct regions in patients with ischemic stroke. Aging Dis. 2018;9(2):287. doi:10.14336/AD.2017.111229896417
   PubMed Web of Science ®Google Scholar
• Kara T, Akaltun İ, Cakmakoglu B, Kaya İ, Zoroğlu S. An investigation of SDF1/CXCR4 gene polymorphisms in autism spectrum disorder: a family-based study. Psychiatry Investig. 2018;15(3):300. doi:10.30773/pi.2017.05.31.2
   Web of Science ®Google Scholar
• Chu T, Shields LB, Zhang YP, Feng S-Q, Shields CB, Cai J. CXCL12/CXCR4/CXCR7 chemokine axis in the central nervous system: therapeutic targets for remyelination in demyelinating diseases. Neuroscientist. 2017;23(6):627–648. doi:10.1177/107385841668569029283028
   PubMed Web of Science ®Google Scholar
• Shroff G, Titus JD, Shroff R. A review of the emerging potential therapy for neurological disorders: human embryonic stem cell therapy. Am J Stem Cells. 2017;6(1):1.28533935
   PubMed Web of Science ®Google Scholar
• Patel RS, Jain SB, Youssef NA. Electroconvulsive treatment utilization for the inpatient management of severe manic episodes of bipolar disorder. J ECT. 2019;35(3):195–200. doi:10.1097/YCT.000000000000058730870263
   PubMed Web of Science ®Google Scholar
• Yamamori H, Hashimoto R, Ishima T, et al. Plasma levels of mature brain-derived neurotrophic factor (BDNF) and matrix metalloproteinase-9 (MMP-9) in treatment-resistant schizophrenia treated with clozapine. Neurosci Lett. 2013;556:37–41. doi:10.1016/j.neulet.2013.09.05924141084
   PubMed Web of Science ®Google Scholar
• Hashimoto K. Sigma-1 receptor chaperone and brain-derived neurotrophic factor: emerging links between cardiovascular disease and depression. Prog Neurobiol. 2013;100:15–29. doi:10.1016/j.pneurobio.2012.09.00123044468
   PubMed Web of Science ®Google Scholar
• Martinowich K, Manji H, Lu B. New insights into BDNF function in depression and anxiety. Nat Neurosci. 2007;10(9):1089–1093. doi:10.1038/nn197117726474
   PubMed Web of Science ®Google Scholar
• Jabłońska-trypuć A, Matejczyk M, Rosochacki S. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs. J Enzyme Inhib Med Chem. 2016;31(sup1):177–183. doi:10.3109/14756366.2016.116162027028474
   PubMed Web of Science ®Google Scholar
• Shibasaki C, Takebayashi M, Itagaki K, et al. Altered serum levels of matrix metalloproteinase-2,-9 in response to electroconvulsive therapy for mood disorders. Int J Neuropsychopharmacol. 2016;19:9. doi:10.1093/ijnp/pyw019
   Web of Science ®Google Scholar
• Cheng X, Wang H, Zhang X, et al. The role of SDF-1/CXCR4/CXCR7 in neuronal regeneration after cerebral ischemia. Front Neurosci. 2017;11:590. doi:10.3389/fnins.2017.0059029123467
   PubMed Web of Science ®Google Scholar
• Zhang X, Liu T, Zhou Z, et al. Enriched environment altered aberrant hippocampal neurogenesis and improved long-term consequences after temporal lobe epilepsy in adult rats. j mol neurosci. 2015;56(2):409–421. doi:10.1007/s12031-015-0571-025946980
   PubMed Web of Science ®Google Scholar
• Zhou Z, Liu T, Sun X, et al. CXCR4 antagonist AMD3100 reverses the neurogenesis promoted by enriched environment and suppresses long-term seizure activity in adult rats of temporal lobe epilepsy. Behav Brain Res. 2017;322(Pt A):83–91. doi:10.1016/j.bbr.2017.01.01428104461
   PubMed Web of Science ®Google Scholar
• Deng QJ, Xu XF, Ren J. Effects of SDF-1/CXCR4 on the repair of traumatic brain injury in rats by mediating bone marrow derived mesenchymal stem cells. Cell Mol Neurobiol. 2018;38(2):467–477. doi:10.1007/s10571-017-0490-428484859
   PubMed Web of Science ®Google Scholar